Newborn screening in Japan

In the 1970's, the government began to take steps for the treatment of congenital diseases. Mass newborn screening was started in October 1977 throughout Japan in order to detect five inborn errors of metabolism including phenylketonuria, maple syrup urine disease, homocystinuria, histidinemia,...

Full description

Saved in:
Bibliographic Details
Published inSoutheast Asian journal of tropical medicine and public health Vol. 34 Suppl 3; p. 80
Main Author Aoki, Kikumaro
Format Journal Article
LanguageEnglish
Published Thailand 2003
Subjects
Blood Specimen Collection
Health Policy
Humans
Infant, Newborn
Japan - epidemiology
Metabolism, Inborn Errors - diagnosis
Metabolism, Inborn Errors - epidemiology
Neonatal Screening - methods
Neonatal Screening - organization & administration
Neonatal Screening - standards
Program Evaluation
Japan
Online AccessGet full text

Cover

More Information
Summary:In the 1970's, the government began to take steps for the treatment of congenital diseases. Mass newborn screening was started in October 1977 throughout Japan in order to detect five inborn errors of metabolism including phenylketonuria, maple syrup urine disease, homocystinuria, histidinemia, and galactosemia. In 1979, mass screening for congenital hypothyroidism was added to the original program. In 1989, screening for congenital adrenal hyperplasia was added and in 1992, screening of histidinemia was discontinued. Currently, screening covers six diseases. The government paid half the cost of screening tests initially and in 2001 this was raised to the full cost (approximately 3000 yen). Parents pay for sample collection. The program is carried out according to law. A new activity involving screening for Wilson disease now necessitates taking dried blood specimens from children 1-3 years old.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:0125-1562